Pathology of Early Hepatocellular Carcinoma: Conventional and Molecular Diagnosis

被引:106
|
作者
Roskams, Tania [1 ]
Kojiro, Masamichi [2 ]
机构
[1] Univ Louvain, Dept Morphol & Mol Pathol, B-3000 Louvain, Belgium
[2] Kurume Univ, Kurume, Fukuoka 830, Japan
关键词
Hepatocellular carcinoma; stromal invasion; dysplastic nodule; glypican-3; heat shock protein 70; glutamine synthetase; nodule-in-nodule; AMMONIA-METABOLIZING ENZYMES; CIRRHOTIC LIVER EXPLANTS; GRADE DYSPLASTIC NODULES; HUMAN HEPATOCARCINOGENESIS; GLUTAMINE-SYNTHETASE; MACROREGENERATIVE NODULES; GLYPICAN-3; EXPRESSION; PRENEOPLASTIC LESIONS; MARKER; CELLS;
D O I
10.1055/s-0030-1247129
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Recently, an East-West consensus on the histopathologic criteria for the diagnosis of high-grade dysplastic nodules (HGDN) versus early hepatocellular carcinoma (HCC) was reached. Next to classical morphologic criteria such as nucleocytoplasmic ratio, thickness of cell plates, mitotic index, and architectural disturbance like acinar structures, one of the most relevant criteria to diagnose early HCC is stromal invasion. Because a structured basement membrane is lacking along the hepatocytes in the liver, invasion cannot be defined as tumor growth through the basement membrane as in other tissues. However, the number of portal tracts that are present in a nodule gradually decrease because the tumoral hepatocytes start to show a destructive invading growth pattern in the mesenchyma/stroma of these portal tracts. This feature of stromal invasion is however sometimes difficult to recognize in needle biopsies because included portal tracts can be absent. Therefore, other diagnostic criteria are necessary. Based on molecular profiling, several additional markers for early malignant HCC have been found recently. Glypican-3, heat shock protein 70, and glutamine synthetase have been already validated and can be used as a panel of stains to confirm the pathologist's histopathologic diagnosis and to solve difficult cases.
引用
收藏
页码:17 / 25
页数:9
相关论文
共 50 条
  • [21] Early Hepatocellular Carcinoma: Definition and Diagnosis
    Kudo, M.
    LIVER CANCER, 2013, 2 (02) : 69 - 72
  • [22] EARLY DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA
    HECHT, Y
    TUBIANA, JM
    GOTHEIL, C
    GAZETTE MEDICALE, 1988, 95 (10): : 35 - &
  • [23] EARLY DIAGNOSIS OF HEPATOCELLULAR-CARCINOMA
    MORENO, SM
    CEJUDO, DR
    MEDICINA CLINICA, 1994, 102 (01): : 35 - 35
  • [24] Biomarkers for the early diagnosis of hepatocellular carcinoma
    Tsuchiya, Nobuhiro
    Sawada, Yu
    Endo, Itaru
    Saito, Keigo
    Uemura, Yasushi
    Nakatsura, Tetsuya
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (37) : 10573 - 10583
  • [25] Molecular Signature of Early Hepatocellular Carcinoma
    Suriawinata, Arief
    Thung, Swan N.
    ONCOLOGY, 2010, 78 : 36 - 39
  • [26] Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinoma
    Ueno, Akihisa
    Masugi, Yohei
    Yamazaki, Ken
    Kurebayashi, Yutaka
    Tsujikawa, Hanako
    Effendi, Kathryn
    Ojima, Hidenori
    Sakamoto, Michiie
    PATHOLOGY INTERNATIONAL, 2020, 70 (03) : 140 - 154
  • [27] Biomarker discovery for early diagnosis of hepatocellular carcinoma
    Shang, S.
    Wang, H.
    Hanash, S.
    Beretta, L.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S204 - S204
  • [28] Early diagnosis of hepatocellular carcinoma by in vivo imaging
    Liang, X.
    Wang, H.
    Zhu, Y.
    Grice, J.
    Liu, X.
    Xu, Z.
    Roberts, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S129 - S130
  • [29] Screening tests for the early diagnosis of hepatocellular carcinoma
    Simon, Krzysztof
    Serafinska, Sylwia
    Pazgan-Simon, Monika
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (04): : 300 - 305
  • [30] Controversies in Surveillance and Early Diagnosis of Hepatocellular Carcinoma
    Kim, Do Young
    Kim, Jin Wook
    Kuromatsu, Ryoko
    Ahn, Sang Hoon
    Torimura, Takuji
    Sherman, Morris
    ONCOLOGY, 2011, 81 : 56 - 60